Status:

RECRUITING

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

Lead Sponsor:

iOMEDICO AG

Collaborating Sponsors:

BeOne Medicines I GmbH Switzerland

Conditions:

Waldenström's Macroglobulinemia

Chronic Lymphocytic Leukemia

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this NIS is to evaluate medical resource utilization, where data is rare in all cohorts, patient's QoL and effectiveness of zanubrutinib treatment in adult patients with WM, CLL, MZL ...

Detailed Description

ARIADNE will collect and analyze data of adult patients with WM, CLL, MZL or FL in need of treatment. The study will explore the medical resource utilization during therapy with zanubrutinib (Brukinsa...

Eligibility Criteria

Inclusion

  • Waldenström's macroglobulinemia (all treatment lines) OR
  • Chronic lymphocytic leukemia (all treatment lines) OR
  • Marginal zone lymphoma (≥2 treatment line and at least one anti-CD20 antibody-based previous therapy)
  • Follicular lymphoma (≥3 treatment line)
  • Signed and dated informed consent form
  • Treatment with zanubrutinib according to current SmPC for WM, CLL and MZL
  • Treatment with zanubrutinib + obinutuzumab for FL according to current SmPC
  • Treatment decision before inclusion into this non-interventional study
  • Age ≥18 years.

Exclusion

  • Contraindications according to SmPC for patients with WM, CLL, MZL or FL
  • Participation in an interventional clinical trial during zanubrutinib treatment.

Key Trial Info

Start Date :

April 26 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2028

Estimated Enrollment :

705 Patients enrolled

Trial Details

Trial ID

NCT05326308

Start Date

April 26 2022

End Date

August 1 2028

Last Update

September 23 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Universitätsklinikum Salzburg, Klinik für Innere Medizin III

Salzburg, Austria, A-5020

2

Lübecker Onkologische Schwerpunktpraxis

Lübeck, Schleswig-Holstein, Germany, D-23562